Rankings
▼
Calendar
CRMD Q3 2021 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$38,088
-59.1% YoY
Gross Profit
$12,922
33.9% margin
Operating Income
-$9M
-22487.2% margin
Net Income
-$9M
-22498.9% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
+365.0%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$75M
Total Liabilities
$6M
Stockholders' Equity
$69M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$38,088
$93,020
-59.1%
Gross Profit
$12,922
$13,107
-1.4%
Operating Income
-$9M
-$7M
-29.7%
Net Income
-$9M
-$7M
-29.8%
← FY 2021
All Quarters
Q4 2021 →